LYN and chronic myelogenous leukemia, BCR-ABL1 positive: LYN mRNA and protein caused cell proliferation, migration and invasion capability of breast cancer [33], chronic myelogenous leukemia [34], prostate cancer [35], colorectal cancer [36], oral cancer [37] and gastric cancer [38].